ResMed RMD Sleep and Breathing Health — Net revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's sleep and breathing health — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ResMed's sleep and breathing health — net revenue?
- ResMed (RMD) reported sleep and breathing health — net revenue of $1.26B in Q1 2026.
- How has ResMed's sleep and breathing health — net revenue changed year-over-year?
- ResMed's sleep and breathing health — net revenue increased by 11.5% year-over-year, from $1.13B to $1.26B.
- What is the long-term trend for ResMed's sleep and breathing health — net revenue?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — net revenue has grown at a 10.0% compound annual growth rate (CAGR), from $3.73B to $4.5B.
- What does sleep and breathing health — net revenue mean?
- This metric represents the total gross sales generated from the company's primary business segment focused on respiratory care devices, including flow generators, masks, and related accessories for sleep apnea treatment. It reflects the core demand for the company's flagship medical technology products and services. This revenue stream is a critical indicator of the company's market penetration and adoption rates within the global sleep and respiratory health market.